Celularity receives Nasdaq delisting notice for late Q1 2024 10-Q and 2023 10-K

Celularity Inc

Nasdaq notified Celularity on May 21, 2024 of non-compliance with Listing Rule 5250(c)(1) for delinquent Q1 2024 10-Q and 2023 10-K.
No immediate delisting; CELU and CELUW continue trading on Nasdaq Capital Market.
Celularity must submit a compliance plan by June 17, 2024; if accepted, has until October 14, 2024 to implement.
Delay in completing the 2023 Form 10-K caused the Q1 2024 filing delay.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.